Merus N.V. Common Shares (MRUS) is a publicly traded Healthcare sector company. As of August 6, 2026, MRUS trades at $90.00 with a market cap of $6.83B and a P/E ratio of -30.00. MRUS moved -7.08% today. Year to date, MRUS is +79.96%; over the trailing twelve months it is +108.82%. Its 52-week range spans $33.19 to $97.14. Analyst consensus is hold with an average price target of $97.00. Rallies surfaces MRUS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
MRUS financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. MRUS recently traded at $90.00. Market cap is $6.83B. P/E ratio is -30.00. Revenue is $43.95M.
| Metric | Value |
|---|---|
| Price | $90.00 |
| Market Cap | $6.83B |
| P/E Ratio | -30.00 |
| EPS | $-3.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $97.14 |
| 52-Week Low | $33.19 |
| Volume | 2.73M |
| Avg Volume | 0 |
| Revenue (TTM) | $43.95M |
| Net Income | $-154.94M |
| Gross Margin | 0.00% |
22 analysts cover MRUS: 0 strong buy, 10 buy, 12 hold, 0 sell, 0 strong sell. Consensus rating is hold. Average price target: $97.00.